In the clinical setting, several groups found an association between high expression of RANK/RANKL/OPG in the primary tumor (e.g. prostate, HCC, not in breast cancer) and propensity to develop bone metastasis (18,20). The gene discussed is TNFSF11; the disease is bone metastasis.